Long-acting beta-agonists reduce mortality of patients with severe and very severe chronic obstructive pulmonary disease: a propensity score matching study

BACKGROUND: Long-acting beta-agonists were one of the first-choice bronchodilator agents for stable chronic obstructive pulmonary disease. But the impact of long-acting beta-agonists on mortality was not well investigated. METHODS: National Emphysema Treatment Trial provided the data. Severe and ver...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Horita, Nobuyuki, Miyazawa, Naoki, Morita, Satoshi, Kojima, Ryota, Kimura, Naoko, Kaneko, Takeshi, Ishigatsubo, Yoshiaki
Formato: Artigo
Idioma:Inglês
Publicado: BioMed Central 2013
Assuntos:
Research
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3674977/
https://ncbi.nlm.nih.gov/pubmed/23725215
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1465-9921-14-62
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares